Homepage Insights News & Events News

De familie Malenstein en NPM Capital hebben overeenstemming bereikt over de voorgenomen investering door Triton in Bergman Clinics

Work highlight
Also in: English
10-03-2021
Loyens & Loeff adviseerde de familie Malenstein en NPM Capital bij de voorgenomen investering door Triton in Bergman Clinics.
Linkedin icon Twiter icon Mail icon
Sectors & Markets
Life Sciences & Healthcare
Expertises
Corporate / M&A Transactional Tax
Linkedin icon Twiter icon Mail icon
Branding icon

Contact us

Anke van Holthe tot Echten
Anke van Holthe tot Echten
Partner
Attorney at Law
Amsterdam
Herman Kaemingk
Herman Kaemingk
Partner
Attorney at Law
Amsterdam
Marjolein  Rekelhof
Marjolein Rekelhof
Senior Associate
Attorney at Law
Amsterdam
Dieuwke Hooft Graafland
Dieuwke Hooft Graafland
Senior Associate
Attorney at Law
Amsterdam
Louis Lutz
Louis Lutz
Partner
Tax Adviser
Amsterdam
Sandrine Lekkerkerker
Sandrine Lekkerkerker
Senior Associate
Tax Adviser
Amsterdam
Freek Hilberdink
Freek Hilberdink
Partner
Civil Law Notary
Amsterdam
Klaas  Wiersma
Klaas Wiersma
Partner
Attorney at Law
Amsterdam
Yacintha Akkoyun
Yacintha Akkoyun
Senior Associate
Deputy Civil Law Notary
Amsterdam
Marita Snoek
Marita Snoek
Associate
Deputy Civil Law Notary
Amsterdam
Return to previous slide
Go to next slide
Other recent news
  • Loyens & Loeff advised Foundever on its recapitalisation and refinancing
    20-08-2026
    Loyens & Loeff advised Foundever on its recapitalisation and refinancing
    Our Banking & Finance, Corporate and Tax teams advised Foundever on the Luxembourg and Dutch aspects of its significant recapitalisation and refinancing transaction.
    Work highlight
  • Living Capital Partners acquires a residential portfolio in Utrecht
    18-08-2026
    Living Capital Partners acquires a residential portfolio in Utrecht
    We advised Living Capital Partners (LCP) on the equity arrangements for its acquisition of a residential complex in Utrecht from a Dutch institutional investor.
    Work highlight
  • Sever Life Sciences agrees on the sale of the Nordic Group B.V. to Alfasigma
    14-08-2026
    Sever Life Sciences agrees on the sale of the Nordic Group B.V. to Alfasigma
    Our Corporate M&A and Tax teams advised Sever Life Sciences on its disposal of Nordic Group B.V., a European specialty pharmaceutical platform to Alfasigma.
    Work highlight
Logo Loyens & Loeff
Linkedin icon
Netherlands Belgium Luxembourg Switzerland
Legal & Privacy